New Drug Application for Niemann-Pick Disease Type C Treatment
source: pixabay.com

New Drug Application for Niemann-Pick Disease Type C Treatment

Orphazyme has recently submitted their New Drug Application to the FDA for their Niemann-Pick disease type C (NPC) treatment, arimoclomol. This application comes after the biopharmaceutical company was already granted…

Continue Reading New Drug Application for Niemann-Pick Disease Type C Treatment